EPO and neoplasm: In hypoxic tumor environments, FOXO4 downregulates hypoxia-inducible factor 1α (HIF-1α), thereby suppressing responses to hypoxia such as the expression of glucose transporter type 1 (GLUT-1), erythropoietin (EPO), and vascular endothelial growth factor.